Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Amgen price outlook ahead of FQ4 earnings
06:08am, Sunday, 06'th Feb 2022
Amgen (NASDAQ: AMGN) will announce fourth-quarter earnings results this Monday, February 07, after the market closes. Amgen shares have weakened slightly above 1% since the beginning of the 2022 year,
3 Biotech Stocks That Could Make You Richer in February (and Beyond)
06:05am, Saturday, 05'th Feb 2022
These companies' share prices could rise in the short term, but their long-term opportunities are even better.
What''s in Amgen''s Q4 Earnings prescription?
06:51pm, Friday, 04'th Feb 2022 Seeking Alpha
Amgen (NASDAQ:AMGN) is scheduled to announce Q4 earnings results on Monday, February 7th, after market close.The consensus EPS Estimate is $4.05 (+6.3% Y/Y) and the consensus
Earnings Previews: Amgen, Simon Property, Tenet Healthcare
12:31pm, Friday, 04'th Feb 2022
While not quite the shock that Meta Platforms sprung on Wednesday, two companies that reported after markets closed Thursday have reversed the sentiment that prevailed.
My Top 10 High Yield Dividend Stocks For February 2022
03:46am, Thursday, 03'rd Feb 2022
I present my top 10 High Yield dividend stocks that are poised to offer strong future returns. The annualized rate of return for this watchlist is 40.16% over the past 15 months.
Was The Smart Money Right About Amgen, Inc. (AMGN)?
08:39pm, Wednesday, 02'nd Feb 2022 Insider Monkey
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is a Beat Likely for Amgen (AMGN) This Earnings Season?
01:04pm, Wednesday, 02'nd Feb 2022
Volume growth from Amgen's (AMGN) key drugs like Prolia, Kyprolis, Repatha and others and biosimilars portfolio is expected to have been partially offset by biosimilar/generic competition for mature d
Amgen, Novartis amend Aimovig licensing and collaboration agreement
11:02pm, Monday, 31'st Jan 2022 Seeking Alpha
Amgen and Novartis have added an amendment to a licensing and collaboration agreement for the migraine medication Aimovig (erenumab).
How to Invest in Biotech When Deep Value Has no Discernible Meaning
10:00am, Monday, 31'st Jan 2022
Biotech's blue bloods are the best bets in the space right now.
Are the Dow's Worst-Performing Stocks of 2021 Ready to Rebound in 2022?
07:42am, Monday, 31'st Jan 2022
Just because a company is a massive household name doesn't always mean investors should jump in after its stock takes a sizable dip.
10 Dividend Growth Stocks For January 2022
09:00am, Sunday, 30'th Jan 2022
I rank a selection of dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration. To pick candidates, I use different screens every month that focus on various as
Mirati Therapeutics: Developing A Drug Potentially Better Than Amgen''s
01:00pm, Saturday, 29'th Jan 2022 Seeking Alpha2 High-Yielding Dividend Stocks That Have Doubled Their Payouts in 7 Years
06:45am, Saturday, 29'th Jan 2022
The big question is, can they continue to increase them?
Can Value Investors Select Amgen (AMGN) Stock Now?
10:46am, Friday, 28'th Jan 2022
Is Amgen (AMGN) a great pick from the value investor's perspective right now? Read on to know more.
Why Amgen (AMGN) Might Surprise This Earnings Season
10:00am, Friday, 28'th Jan 2022
Amgen (AMGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
